+ Translate

Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus

, : Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus. Gut 30(9): 1279-1284

The effects of meal volume and luminal digestion of carbohydrates on the release of pancreatic polypeptide (HPP) were investigated in eight healthy subjects and in six patients who had non-insulin dependent diabetes mellitus. On one occasion each subject ingested a placebo with 200 ml water and a starch (50 g) pudding meal (400 ml) 30 minutes later. On another occasion an amylase inhibitor that retards intraluminal starch digestion was given with the water and starch. In normal subjects, water caused a moderate rise in HPP plasma levels (16.9 (10.9) pg/ml; p less than 0.02) and ingestion of starch increased HPP in a double peaked pattern. The mean increments of the peaks were 45.0 (15.2) pg/ml (p less than 0.02) and 41.1 (17.3) pg/ml (p less than 0.05), respectively. In the diabetic subjects, the HPP concentrations did not increase in response to water. After ingestion of starch the diabetics had two peaks of HPP that were similar in magnitude, but the early postprandial peak was delayed significantly compared to normal subjects (37.5 (5.1) min v 23.4 (3.9) min; p less than 0.05). The amylase inhibitor (5 or 10 g) reduced the early postprandial HPP peak by 79% (p less than 0.05) in normal subjects and 4 g of the inhibitor reduced the early HPP peak by 58% (p less than 0.05) in the diabetics. In both groups ingestion of the amylase inhibitor abolished the late HPP peak (p less than 0.05). In conclusion, carbohydrate induced HPP release is dependent on undisturbed intraluminal starch digestion.

(PDF same-day service: $19.90)

Accession: 002042896

PMID: 2478426

DOI: 10.1136/gut.30.9.1279

Submit PDF Full Text: Here

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Chowdhury, S.; Wang, S.; Patterson, B.W.; Reeds, D.N.; Wice, B.M., 2014: The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus. Xenin-25 (Xen) is a 25-amino acid neurotensin-related peptide that activates neurotensin receptor-1 (NTSR1). We previously showed that Xen increases the effect of glucose-dependent insulinotropic polypeptide (GIP) on insulin release 1) in hypergly...

Okano H.; Saeki S.; Morimoto S.; Ohmoto A.; Nakashima T.; Miyamoto M.; O.T.; Kawai Y.; Takata A.; E.A., 1990: The relationship of gastric gallbladder emptying and human pancreatic polypeptide release in patients with insulin dependent diabetes mellitus iddm. Gastroenterology 98(5 PART 2): A378

Maxwell, J.E.; O'Dorisio, T.M.; Bellizzi, A.M.; Howe, J.R., 2014: Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?. Pancreatic neuroendocrine tumors (PNETs) that secrete primarily pancreatic polypeptide (PP) are rare and usually nonfunctional. There are approximately 2 dozen reports of PP-secreting PNETs, 3 of which have been associated with diabetes mellitus (...

Hart, P.A.; Baichoo, E.; Bi, Y.; Hinton, A.; Kudva, Y.C.; Chari, S.T., 2015: Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus. Pancreatology 15(2): 162-166

Song, M.; Zhu, J.; He, M., 1997: The morphometric measurement of the weights of the pancreatic polypeptide lobe and non-polypeptide lobe of steroid diabetes mellitus. The weights of the pancreatic polypeptide lobe (PP lobe) and non-polypeptide lobe (non-PP lobe) of autopsied specimens were measured by morphometry in 11 cases of steroid diabetes mellitus (SDM), and in 9 cases of non-insulin dependent diabetes me...

Inoue, Y.; Tasaka, Y.; Odagiri, R.; Hirata, Y., 1983: Response of plasma pancreatic polypeptide in diabetes mellitus. Horumon to Rinsho. Clinical Endocrinology 31(6): 499-503

Rogers, W.A.; O'Dorisio, T.M.; Johnson, S.E.; Cataland, S.; Stradley, R.P.; Sherding, R.G., 1983: Postprandial release of gastric inhibitory polypeptide (GIP) and pancreatic polypeptide in dogs with pancreatic acinar atrophy. Correction of blunted GIP response by addition of pancreatic enzymes to a meal. To evaluate the enteropancreatic hormone axis in dogs with pancreatic acinar atrophy, the release of gastric inhibitory polypeptide and pancreatic polypeptide in response to a standard meal and a meal containing pancreatic enzymes was estimated in...

Miyasaka K.; Kitani K.; Miyazaki K.; Funakoshi A., 1987: The release of pancreatic polypeptide and the effect of exogenous rat pancreatic polypeptide on pancreatic exocrine secretion in atropinized conscious rats. Gastroenterology 92(5 PART 2): 1537

Layer P.; G.V.L.W.; Dimagno E.P., 1986: Nutrient but not volume induced pancreatic polypeptide release in humans is dependent on intact luminal digestion. Digestion 35(1): 36

Domschke, S.; Bloom, S.R.; Adrian, T.E.; Lux, G.; Domschke, W., 1988: Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin). A disturbed intraduodenal milieu and pancreatic scarring in advanced chronic pancreatitis (CP) may lead to changes of gut and pancreatic hormones. In the present study, the gastroduodenal mucosal content of several regulatory peptides was determin...